Are you Dr. Carlson?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 32 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Bosley Medical Group
1601 Market St, Ste 2410
Philadelphia, PA 19103Phone+1 215-564-4444
Summary
- Dr. Eric Carlson, MD is an ophthalmologist in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania, Arizona, and Georgia.
Education & Training
University of Pennsylvania Health SystemResidency, Otolaryngology - Head and Neck Surgery, 1978 - 1981
University of Missouri-Columbia School of MedicineInternship, Transitional Year, 1975 - 1976
University of Missouri-Columbia School of MedicineClass of 1975
Certifications & Licensure
CA State Medical License 2001 - Present
NJ State Medical License 1995 - 2025
PA State Medical License 1978 - 2024
FL State Medical License 2001 - 2010
AZ State Medical License 2002 - 2009
GA State Medical License 2002 - 2009
IL State Medical License 2001 - 2008- American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
- Join now to see all
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 42 citationsThoracic Aortic Aneurysm Frequency and Dissection are Associated with Fibrillin-1 Fragment Concentrations in CirculationLynn M. Marshall, Eric J. Carlson, Jean P. O'Malley, Caryn K. Snyder, Noe L. Charbonneau
Circulation Research. 2013-10-25 - 37 citationsSex, pregnancy and aortic disease in Marfan syndromeMarjolijn Renard, Laura Muiño-Mosquera, Elise C. Manalo, Sara F. Tufa, Eric J. Carlson
Plos One. 2017-07-14 - 107 citationsMicroenvironmental Regulation by Fibrillin-1Gerhard Sengle, Ko Tsutsui, Douglas R. Keene, Sara F. Tufa, Eric J. Carlson
Plos Genetics. 2012-01-05
Press Mentions
Oyster Point Pharma Strengthens Executive Leadership Team with the Appointment of Chief Medical and Chief Scientific OfficersDecember 7th, 2020- Oyster Point Pharma Strengthens Executive Leadership Team with the Appointment of Chief Medical and Chief Scientific OfficersDecember 7th, 2020
Professional Memberships
- Member
